Title |
Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats
|
---|---|
Published in |
Psychopharmacology, January 2010
|
DOI | 10.1007/s00213-009-1760-8 |
Pubmed ID | |
Authors |
Anne-Sophie Villégier, Brittney Gallager, Jon Heston, James D. Belluzzi, Frances M. Leslie |
Abstract |
Epidemiological studies have demonstrated a comorbidity of smoking with depression and anxiety, particularly during adolescence. However, few animal studies have considered possible synergistic interactions between nicotine and other tobacco smoke constituents, such as monoamine oxidase (MAO) inhibitors, in the regulation of mood. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 150% |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Czechia | 1 | 2% |
Unknown | 56 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 14% |
Researcher | 8 | 14% |
Student > Bachelor | 8 | 14% |
Professor | 5 | 9% |
Student > Doctoral Student | 5 | 9% |
Other | 12 | 21% |
Unknown | 11 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 11 | 19% |
Agricultural and Biological Sciences | 8 | 14% |
Neuroscience | 5 | 9% |
Medicine and Dentistry | 5 | 9% |
Nursing and Health Professions | 3 | 5% |
Other | 11 | 19% |
Unknown | 14 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 February 2022.
All research outputs
#14,992,720
of 23,063,209 outputs
Outputs from Psychopharmacology
#4,187
of 5,370 outputs
Outputs of similar age
#135,452
of 166,076 outputs
Outputs of similar age from Psychopharmacology
#19
of 21 outputs
Altmetric has tracked 23,063,209 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,370 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,076 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.